4//SEC Filing
BALLIET JENNIFER 4
Accession 0001077183-20-000223
CIK 0001077183other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 5:57 PM ET
Size
12.3 KB
Accession
0001077183-20-000223
Insider Transaction Report
Form 4
BALLIET JENNIFER
Vice President of HR
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2020-12-11−15,000→ 33,334 totalExercise: $8.03Exp: 2023-02-26→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2020-12-11$8.03/sh+15,000$120,450→ 39,980 total - Sale
Common Stock
2020-12-11$49.99/sh−15,000$749,850→ 24,980 total
Holdings
- 7,000
Stock Option (Right to Buy)
Exercise: $7.52Exp: 2022-04-28→ Common Stock (7,000 underlying) - 15,006
Stock Option (Right to Buy)
Exercise: $28.33Exp: 2027-03-02→ Common Stock (15,006 underlying) - 17,496
Stock Option (Right to Buy)
Exercise: $19.60Exp: 2024-03-01→ Common Stock (17,496 underlying)
Footnotes (4)
- [F1]On April 28, 2017, Ms. Balliet was granted 60,000 stock options. These options vested ratably over the first three anniversaries of the grant date.
- [F2]On February 26, 2018, Ms. Balliet was granted 72,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F3]On March 1, 2019, Ms. Balliet was granted 17,496 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F4]On March 2, 2020, Ms. Balliet was granted 15,006 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001640500
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 5:57 PM ET
- Size
- 12.3 KB